Medical Journals

Neuronal Nitric Oxide Mediates Cerebral Vasodilatation During Acute Hypertension.

Authors:
  • Talman William T
  • Nitschke Dragon Deidre

From: Laboratory of Neurobiology, Department of Neurology, VAHCS, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA. william-talman@uiowa.edu

Brain research

  • Publish Date: Mar 2007
  • ISSN: 0006-8993
  • Volume: 1139
  • Issue:
  • Pages: 126-32
  • Medium: Print
  • Language: English
  • Citation (JAMA): Talman William T, Nitschke Dragon Deidre, et al. Neuronal Nitric Oxide Mediates Cerebral Vasodilatation During Acute Hypertension.. Brain Res. Mar 2007;1139:126-32

Abstract

Parasympathetic nerves from the pterygopalatine ganglia provide nitroxidergic innervation to forebrain cerebral blood vessels. Disruption of that innervation attenuates cerebral vasodilatation seen during acute hypertension as does systemic administration of a non-selective nitric oxide synthase (NOS) inhibitor. Although such studies suggest that nitric oxide (NO) released from parasympathetic nerves participates in vasodilatation of cerebral vessels during hypertension, that hypothesis has not been tested with selective local inhibition of neuronal NOS (nNOS). We tested that hypothesis through these studies performed in anesthetized rats instrumented for continuous measurement of blood pressure, heart rate and pial arterial diameter through a cranial window. We sought to determine if the nNOS inhibitor propyl-L-arginine delivered directly to the outer surface of a pial artery would (1) attenuate changes in pial arterial diameter during acute hypertension and (2) block nNOS-mediated dilator effects of N-methyl-D-aspartate (NMDA) delivered into the window but (3) not block vasodilatation elicited by acetylcholine (ACh) and mediated by endothelial NOS dilator. Without the nNOS inhibitor arterial diameter abruptly increased 70+/-15% when mean arterial pressure (MAP) reached 183+/-3 mm Hg while with nNOS inhibition diameter increased only 13+/-10% (p<0.05) even when MAP reached 191+/-4 mm Hg (p>0.05). The nNOS inhibitor significantly attenuated vasodilatation induced by NMDA but not ACh delivered into the window. Thus, local nNOS inhibition attenuates breakthrough from autoregulation during hypertension as does complete interruption of the parasympathetic innervation of cerebral vessels. These findings further support the hypothesis that NO released from parasympathetic fibers contributes to cerebral vasodilatation during acute hypertension.

Mesh Headings (Keywords): Animals, Arginine, Blood Pressure, Cerebral Cortex, Cerebrovascular Circulation, Hypertension, Male, Nitric Oxide Synthase Type I, Parasympathetic Nervous System, Rats, Rats, Sprague-Dawley, Vasodilation


Check for Full Text / PubMed Unique Identifier (PMID): 17291465


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.